Țară: Spania
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
cefquinome 25 mg/ml
Intervet UK Limited
QJ51DA92
Suspension for injection
cefquinome
Cattle Food, Pigs Food
2011-09-23
Revised: April 2012 AN: 01965/2011 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COBACTAN 2.5% w/v suspension for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml suspension for injection contains: ACTIVE SUBSTANCE: Cefquinome (as sulfate) 25 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of bacterial infections in cattle and pigs caused by the Gram positive and Gram negative microorganisms sensitive to cefquinome. Cattle: Respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica Digital dermatitis, infectious bulbar necrosis and acute interdigital necrobacillosis (foul in the foot) Acute _E.coli_ mastitis with signs of systemic involvement Calves: _ _ _E.coli_ septicaemia in calves Pigs: For the treatment of bacterial infections of the lungs and respiratory tract caused by _Pasteurella multocida, Haemophilus parasuis, Actinobacillus _ _pleuropneumoniae, Streptococcus suis_ and other cefquinome-sensitive organisms Revised: April 2012 AN: 01965/2011 Page 2 of 7 Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of _E.coli, _ _Staphylococcus spp., Streptococcus spp_. and other cefquinome sensitive organisms Piglets: Reduction of mortality in cases of meningitis caused by _Streptococcus _ _suis_. For the treatment of: Arthritis caused Citiți documentul complet